National Bank of Canada’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107M | Buy |
240,378
+99,751
| +71% | +$44.4M | 0.1% | 150 |
|
|
2025
Q1 | $68.2M | Sell |
140,627
-14,173
| -9% | -$6.87M | 0.07% | 211 |
|
|
2024
Q4 | $62.3M | Sell |
154,800
-75,698
| -33% | -$30.5M | 0.07% | 219 |
|
|
2024
Q3 | $107M | Buy |
230,498
+128,061
| +125% | +$59.6M | 0.12% | 140 |
|
|
2024
Q2 | $48.3M | Sell |
102,437
-33,696
| -25% | -$15.9M | 0.07% | 200 |
|
|
2024
Q1 | $57.6M | Sell |
136,133
-100,264
| -42% | -$42.4M | 0.09% | 166 |
|
|
2023
Q4 | $97.1M | Buy |
236,397
+112,007
| +90% | +$46M | 0.16% | 118 |
|
|
2023
Q3 | $43.2M | Sell |
124,390
-74,020
| -37% | -$25.7M | 0.07% | 202 |
|
|
2023
Q2 | $69M | Buy |
198,410
+147,671
| +291% | +$51.4M | 0.13% | 132 |
|
|
2023
Q1 | $16M | Sell |
50,739
-87,430
| -63% | -$27.6M | 0.04% | 278 |
|
|
2022
Q4 | $39.9M | Buy |
138,169
+89,411
| +183% | +$25.8M | 0.1% | 160 |
|
|
2022
Q3 | $14.3M | Buy |
48,758
+7,622
| +19% | +$2.24M | 0.08% | 252 |
|
|
2022
Q2 | $11.7M | Buy |
41,136
+5,060
| +14% | +$1.44M | 0.05% | 288 |
|
|
2022
Q1 | $10.3M | Buy |
36,076
+29,337
| +435% | +$8.34M | 0.03% | 343 |
|
|
2021
Q4 | $1.49M | Buy |
+6,739
| New | +$1.49M | 0.01% | 776 |
|